Cathaline den Besten

1.0k total citations
22 papers, 695 citations indexed

About

Cathaline den Besten is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Cathaline den Besten has authored 22 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Cathaline den Besten's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Cathaline den Besten is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Cathaline den Besten collaborates with scholars based in Netherlands, United Kingdom and United States. Cathaline den Besten's co-authors include Peter J. van Bladeren, Ivonne M.C.M. Rietjens, Greet Vansant, Paul Deurenberg, JA Weststrate, Ben van Ommen, Robert P. Hanzlik, Rudolf B. Beems, R.M.E. Vos and Franz Müller and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Clinical Nutrition and Biochemical and Biophysical Research Communications.

In The Last Decade

Cathaline den Besten

21 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathaline den Besten Netherlands 17 346 114 85 75 62 22 695
Fumiaki Shono Japan 15 226 0.7× 118 1.0× 117 1.4× 95 1.3× 94 1.5× 54 657
C.A. Tyson United States 14 371 1.1× 179 1.6× 73 0.9× 43 0.6× 47 0.8× 24 825
Walid A. Al-Turk United States 14 181 0.5× 135 1.2× 73 0.9× 39 0.5× 28 0.5× 40 609
W. Griffith Humphreys United States 13 410 1.2× 183 1.6× 43 0.5× 96 1.3× 38 0.6× 17 849
H Graf Germany 15 275 0.8× 131 1.1× 51 0.6× 30 0.4× 40 0.6× 23 565
John R. Cashman United States 18 258 0.7× 282 2.5× 75 0.9× 70 0.9× 66 1.1× 31 769
Victor M. Samokyszyn United States 18 462 1.3× 196 1.7× 57 0.7× 79 1.1× 19 0.3× 32 1.0k
Hans Helleberg Denmark 8 292 0.8× 51 0.4× 48 0.6× 168 2.2× 58 0.9× 18 783
Yuichiro Kanno Japan 21 385 1.1× 217 1.9× 68 0.8× 104 1.4× 21 0.3× 60 886
L Clejan United States 17 379 1.1× 157 1.4× 59 0.7× 22 0.3× 47 0.8× 36 652

Countries citing papers authored by Cathaline den Besten

Since Specialization
Citations

This map shows the geographic impact of Cathaline den Besten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathaline den Besten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathaline den Besten more than expected).

Fields of papers citing papers by Cathaline den Besten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathaline den Besten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathaline den Besten. The network helps show where Cathaline den Besten may publish in the future.

Co-authorship network of co-authors of Cathaline den Besten

This figure shows the co-authorship network connecting the top 25 collaborators of Cathaline den Besten. A scholar is included among the top collaborators of Cathaline den Besten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathaline den Besten. Cathaline den Besten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Besten, Cathaline den, Matthew H. Rigby, Martin Corsten, et al.. (2025). Outcomes Following Transoral Laser Microsurgery for T1b and T2a Glottic Squamous Cell Carcinoma With and Without Anterior Commissure Involvement: A Retrospective Chart Review. Journal of Otolaryngology - Head and Neck Surgery. 54. 2071672264–2071672264.
2.
Bosgra, Sieto, Jessica A. Sipkens, S. de Kimpe, et al.. (2019). The Pharmacokinetics of 2′- O -Methyl Phosphorothioate Antisense Oligonucleotides: Experiences from Developing Exon Skipping Therapies for Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. 29(6). 305–322. 22 indexed citations
3.
Dulla, Kalyan, Iris A. Schulkens, Wouter Beumer, et al.. (2019). QR-421a, an antisense oligonucleotide, for the treatment of retinitis pigmentosa due to USH2A exon 13 mutations. Investigative Ophthalmology & Visual Science. 60(9). 3250–3250. 8 indexed citations
4.
Janssen, Manoe J., Tom T.G. Nieskens, Tessa A. M. Steevels, et al.. (2019). Therapy with 2′-O-Me Phosphorothioate Antisense Oligonucleotides Causes Reversible Proteinuria by Inhibiting Renal Protein Reabsorption. Molecular Therapy — Nucleic Acids. 18. 298–307. 19 indexed citations
5.
Kim, Jaeah, et al.. (2019). Metabolite Profiling of the Antisense Oligonucleotide Eluforsen Using Liquid Chromatography-Mass Spectrometry. Molecular Therapy — Nucleic Acids. 17. 714–725. 41 indexed citations
6.
Capaldi, Daniel C., Scott P. Henry, Cathaline den Besten, et al.. (2017). Impurities in Oligonucleotide Drug Substances and Drug Products. Nucleic Acid Therapeutics. 27(6). 309–322. 95 indexed citations
7.
8.
Lange, Jos H.M., Jennifer Venhorst, Maria J. P. van Dongen, et al.. (2011). Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors. European Journal of Medicinal Chemistry. 46(10). 4808–4819. 21 indexed citations
9.
Rietjens, Ivonne M.C.M., et al.. (1995). Comparative biotransformation of hexachlorobenzene and hexafluorobenzene in relation to the induction of porphyria. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 293(4). 293–299. 7 indexed citations
10.
Besten, Cathaline den, et al.. (1994). Comparison of the urinary metabolite profiles of hexachlorobenzene and pentachlorobenzene in the rat. Chemico-Biological Interactions. 90(2). 121–137. 14 indexed citations
11.
Besten, Cathaline den, Abraham Brouwer, Ivonne M.C.M. Rietjens, & Peter J. van Bladeren. (1994). Biotransfiormation and Toxicity of Halogenated Benzenes. Human & Experimental Toxicology. 13(12). 866–875. 21 indexed citations
12.
Besten, Cathaline den, Peter J. van Bladeren, Erwin Duizer, Jacques Vervoort, & Ivonne M.C.M. Rietjens. (1993). Cytochrome P450-mediated oxidation of pentafluorophenol to tetrafluorobenzoquinone as the primary reaction product. Chemical Research in Toxicology. 6(5). 674–680. 36 indexed citations
13.
Besten, Cathaline den, et al.. (1992). The involvement of primary and secondary metabolism in the covalent binding of 1,2- and 1,4-dichlorobenzenes. Chemico-Biological Interactions. 84(3). 259–275. 28 indexed citations
14.
Besten, Cathaline den, et al.. (1991). The liver, kidney, and thyroid toxicity of chlorinated benzenes. Toxicology and Applied Pharmacology. 111(1). 69–81. 75 indexed citations
15.
Besten, Cathaline den, et al.. (1991). Metabolic activation of 1,2,4-trichlorobenzene and pentachlorobenzene by rat liver microsomes: A major role for quinone metabolites. Toxicology and Applied Pharmacology. 108(2). 223–233. 22 indexed citations
16.
Besten, Cathaline den, et al.. (1990). Studies on the mechanism of coumarin-induced toxicity in rat hepatocytes. Toxicology in Vitro. 4(4-5). 518–521. 17 indexed citations
17.
Besten, Cathaline den, Melanie Peters, & Peter J. van Bladeren. (1989). The metabolism of pentachlorobenzene by rat liver microsomes: The nature of the reactive intermediates formed. Biochemical and Biophysical Research Communications. 163(3). 1275–1281. 17 indexed citations
18.
Vansant, Greet, et al.. (1988). Body fat distribution and the prognosis for weight reduction: preliminary observations.. PubMed. 12(2). 133–40. 34 indexed citations
19.
Bladeren, Peter J. van, Cathaline den Besten, I.M. Bruggeman, et al.. (1988). Glutathione conjugation as a toxication reaction.. Socio-Environmental Systems Modeling. 267–274. 2 indexed citations
20.
Ommen, Ben van, Cathaline den Besten, J.H.T.M. Ploemen, et al.. (1988). Active site-directed irreversible inhibition of glutathione S-transferases by the glutathione conjugate of tetrachloro-1,4-benzoquinone.. Journal of Biological Chemistry. 263(26). 12939–12942. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fumiaki Shono Breakdown of academic impact, for papers by C.A. Tyson Breakdown of academic impact, for papers by Walid A. Al-Turk Breakdown of academic impact, for papers by W. Griffith Humphreys Breakdown of academic impact, for papers by H Graf Breakdown of academic impact, for papers by John R. Cashman Breakdown of academic impact, for papers by Victor M. Samokyszyn Breakdown of academic impact, for papers by Hans Helleberg Breakdown of academic impact, for papers by Yuichiro Kanno Breakdown of academic impact, for papers by L Clejan
Rankless by CCL
2026